The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial
Abstract
OBJECTIVE: To present the results (to January 1996, the end of blinded treatment) of the Nutritional Prevention of Cancer (NPC) Trial, a randomized trial of selenium (200 µg daily) designed to test the hypothesis that selenium supplementation (SS) could reduce the risk of recurrent nonmelanoma skin cancer among 1312 residents of the Eastern USA. MATERIALS AND METHODS: Original secondary analyses of the NPC to 1993 showed striking inverse associations between SS and prostate cancer incidence. A subsequent report revealed that this effect was accentuated among men with the lowest baseline plasma selenium concentrations. The effects of treatment overall and within subgroups of baseline prostate‐specific antigen (PSA) and plasma selenium concentrations were examined using incidence rate ratios and Cox proportional hazards models. RESULTS: SS continued to significantly reduce the overall incidence (relative risk and 95% confidence interval) of prostate cancer (0.51, 0.29–0.87). The protective effect of SS appeared to be confined to those with a baseline PSA level of ≤ 4 ng/mL (0.35, 0.13–0.87), although the interaction of baseline PSA and treatment was not statistically significant. Participants with baseline plasma selenium concentrations only in the lowest two tertiles (< 123.2 ng/mL) had significant reductions in prostate cancer incidence. A significant interaction between baseline plasma selenium and treatment was detected. CONCLUSION: To the end of the blinded treatment the NPC trial continued to show a significant protective effect of SS on the overall incidence of prostate cancer, although the effect was restricted to those with lower baseline PSA and plasma selenium concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clark, L. (1996) · JAMA · doi:10.1001/jama.276.24.1957 · Cited by 2,719
Self-citationCatalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., Dekernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., et al. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35233-3 · Cited by 1,592
Self-citationClark, Dalkin, Krongrad, Jr, C., Turnbull, Slate, Witherington, Herlong, Janosko, Carpenter, et al. (1998) · British Journal of Urology · doi:10.1046/j.1464-410x.1998.00630.x · Cited by 673
PREDIAGNOSTIC SERUM SELENIUM AND RISK OF CANCER
Willett, W., Steven Morris, J., Pressel, S., Taylor, J., Frank Polk, B., Stampfer, M., Rosner, B., Schneider, K., & Hames, C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90116-2 · Cited by 548
Study of Prediagnostic Selenium Level in Toenails and the Risk of Advanced Prostate Cancer
Yoshizawa, K., Willett, W. C., Morris, S. J., Stampfer, M. J., Spiegelman, D., Rimm, E. B., & Giovannucci, E. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.16.1219 · Cited by 536
Association Between alpha-Tocopherol, gamma-Tocopherol, Selenium, and Subsequent Prostate Cancer
Helzlsouer, K. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2018 · Cited by 391
West, D. W., Slattery, M. L., Robison, L. M., French, T. K., & Mahoney, A. W. (1991) · Cancer Causes and Control · doi:10.1007/bf00053126 · Cited by 370
SELECT: THE NEXT PROSTATE CANCER PREVENTION TRIAL
KLEIN, E. A., THOMPSON, I. M., LIPPMAN, S. M., GOODMAN, P. J., ALBANES, D., TAYLOR, P. R., & COLTMAN, C. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65759-x · Cited by 257
Jiang, C., Wang, Z. P., Ganther, H. E., & Lü, J. (2001) · PubMed · Cited by 249
PLASMA SELENIUM LEVEL BEFORE DIAGNOSIS AND THE RISK OF PROSTATE CANCER DEVELOPMENT
BROOKS, J. D., METTER, E. J., CHAN, D. W., SOKOLL, L. J., LANDIS, P., NELSON, W. G., MULLER, D., ANDRES, R., & CARTER, H. B. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65500-0 · Cited by 231
Cited by
Rayman, M. P. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61452-9 · Cited by 3,563
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S., Thompson, I. M., Ford, L. G., Parnes, H. L., Minasian, L. M., Gaziano, J. M., Hartline, J. A., et al. (2009) · JAMA · doi:10.1001/jama.2008.864 · Cited by 2,122
Kushi, L. H., Byers, T., Doyle, C., Bandera, E. V., McCullough, M., Gansler, T., Andrews, K. S., Thun, M. J., & The American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.5.254 · Cited by 1,901
Metadata
- Authors
- Duffield‐Lillico, A. J., Dalkin, B. L., Reid, M. E., Turnbull, B. W., Slate, E. H., Jacobs, E. T., Marshall, J. R., Clark, L. C., & for the Nutritional Prevention of Cancer Study Group
- Venue
- BJU International
- Publisher
- Wiley
- Published
- 2003-04-16
- Volume
- 91
- Issue
- 7
- Pages
- 608-612
- ISSN
- 1464-4096 (ISSN-L)
- 1464-410X
- OpenAlex
- W1582872071
- Cited by
- 514
- References
- 15
- FWCI
- 23.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. https://app.cochat.ai/papers/10.1046/j.1464-410x.2003.04167.x
- The paper
- Duffield‐Lillico, A. J., Dalkin, B. L., Reid, M. E., Turnbull, B. W., Slate, E. H., Jacobs, E. T., Marshall, J. R., Clark, L. C., & for the Nutritional Prevention of Cancer Study Group. (2003). Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU International. https://doi.org/10.1046/j.1464-410x.2003.04167.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.